Dexcel Pharma Technologies Ltd.

Average Profitability
38.38%
Insider Buys Quantity
3
Insider Buys Sum
$40.15M
Insider Sells Quantity
2
Insider Sells Sum
$2.09M

Insider Activity of Dexcel Pharma Technologies Ltd.

The largest purchase of all time was on 2022-11-10 and amounted to 8000000 shares of Roivant Sciences Ltd. for $40M.

The largest sale of all time was on 2021-06-03 and amounted to 857506 shares of Protalix BioTherapeutics, Inc. for $1.93M.

Biography of Dexcel Pharma Technologies Ltd.

No biography is available at this moment.

2022-11-10PurchaseRoivant Sciences Ltd.
ROIV
director
8M
1.0825%
$5.00$40M+73.75%
2022-04-25PurchaseRoivant Sciences Ltd.
ROIV
10 percent owner
8,600
0.0012%
$3.91$33,635+19.01%
2022-04-22PurchaseRoivant Sciences Ltd.
ROIV
10 percent owner
31,685
0.0045%
$3.83$121,319+22.38%
2021-06-03SaleProtalix BioTherapeutics, Inc.
PLX
10 percent owner
857,506
1.9156%
$2.25$1.93M-48.2%
2021-06-02SaleProtalix BioTherapeutics, Inc.
PLX
10 percent owner
61,211
0.1389%
$2.56$156,553-53.63%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.